Revium Rx utilizes a novel drug delivery technology to develop encapsulated therapeutics for several therapeutic indications, including antibiotics for antimicrobial-resistant bacteria, a lipid-based adjuvant for solid carcinogenic tumors, and immunization. 
Our technology integrates well-defined active substances with a proprietary, clinically proven drug-loading process to produce lipid-based particle carrier compositions that address unmet clinical needs in key fields such as infectious diseases, cancer, and immunology.

Revium RX

Org chart

Teams

Offices